Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.

Item
http://www.wikidata.org/entity/Q34269632
Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanismsBerberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine.Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.Recent advances in pharmacological treatment of irritable bowel syndrome.Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations.Pharmacological agents currently in clinical trials for disorders in neurogastroenterology.Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases.Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas.Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review.GLP-1 based therapies: clinical implications for gastroenterologists.Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons.Glucagon-like peptide-1 exerts anti-inflammatory effects on mouse colon smooth muscle cells through the cyclic adenosine monophosphate/nuclear factor-κB pathway in vitro.Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders.
P2860

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.

Item
http://www.wikidata.org/entity/Q34269632
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Effect of a glucagon-like pept ...... nant irritable bowel syndrome.
@ast
Effect of a glucagon-like pept ...... nant irritable bowel syndrome.
@en
Effect of a glucagon-like pept ...... nant irritable bowel syndrome.
@nl
type
label
Effect of a glucagon-like pept ...... nant irritable bowel syndrome.
@ast
Effect of a glucagon-like pept ...... nant irritable bowel syndrome.
@en
Effect of a glucagon-like pept ...... nant irritable bowel syndrome.
@nl
prefLabel
Effect of a glucagon-like pept ...... nant irritable bowel syndrome.
@ast
Effect of a glucagon-like pept ...... nant irritable bowel syndrome.
@en
Effect of a glucagon-like pept ...... nant irritable bowel syndrome.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Effect of a glucagon-like pept ...... nant irritable bowel syndrome.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698